[{"address1": "Wallstra\u00dfe 16", "city": "Berlin", "zip": "10179", "country": "Germany", "phone": "49 89 2153 9035", "website": "https://atai.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin that is in Phase 2a and 2b clinical studies for treatment resistant depression (TRD) and alcohol use disorder; RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator in Phase 2b trial for cognitive impairment associated with schizophrenia; and ELE-101, a serotonergic psychedelic in Phase 2a trial for the treatment of major depressive disorder. It is also developing VLS-01, an oral transmucosal film formulation of N,N-Dimethyltryptamine in Phase 2 clinical study to treat TRD; EMP-01, an oral formulation of R-3,4-methylenedioxy-methamphetamine that is in Phase 2 clinical study for social anxiety disorder; and EGX-A & EGX-B, which are non-hallucinogenic 5-HT2A receptor agonists in preclinical studies for TRD. In addition, the company offers COMP360 for psilocybin therapy; and GRX-917 for the treatment of anxiety, depression, and various neurological disorders. ATAI Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany.", "fullTimeEmployees": 54, "companyOfficers": [{"maxAge": 1, "name": "Mr. Christian  Angermayer", "age": 46, "title": "Founder & Chairman of the Supervisory Board", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 70000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Srinivas G. Rao M.D., Ph.D.", "age": 55, "title": "Co-Founder & CEO", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 793650, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Anne  Johnson", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 494232, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gerd G. Kochendoerfer Ph.D.", "age": 56, "title": "Chief Operating Officer", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Glenn  Short Ph.D.", "age": 54, "title": "Chief Scientific Officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan  Barrett J.D.", "age": 42, "title": "General Counsel & Corporate Secretary", "yearBorn": 1982, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sahil V. Kirpekar M.D.", "age": 37, "title": "Chief Business Officer", "yearBorn": 1987, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kevin  Craig M.D.", "age": 51, "title": "Chief Medical Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.42, "open": 1.42, "dayLow": 1.42, "dayHigh": 1.505, "regularMarketPreviousClose": 1.42, "regularMarketOpen": 1.42, "regularMarketDayLow": 1.42, "regularMarketDayHigh": 1.505, "payoutRatio": 0.0, "beta": 1.247, "forwardPE": -2.1617646, "volume": 1652006, "regularMarketVolume": 1652006, "averageVolume": 2782438, "averageVolume10days": 1644820, "averageDailyVolume10Day": 1644820, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 291509824, "fiftyTwoWeekLow": 1.03, "fiftyTwoWeekHigh": 2.565, "priceToSalesTrailing12Months": 946.46045, "fiftyDayAverage": 1.6182, "twoHundredDayAverage": 1.436, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 256343488, "profitMargins": 0.0, "floatShares": 108999143, "sharesOutstanding": 198306000, "sharesShort": 11682579, "sharesShortPriorMonth": 10956604, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.0589, "heldPercentInsiders": 0.08527, "heldPercentInstitutions": 0.29183, "shortRatio": 6.52, "shortPercentOfFloat": 0.073699996, "impliedSharesOutstanding": 198306000, "bookValue": 0.692, "priceToBook": 2.1242776, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -149268992, "trailingEps": -0.93, "forwardEps": -0.68, "enterpriseToRevenue": 832.284, "enterpriseToEbitda": -2.582, "52WeekChange": -0.21390373, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 1.47, "targetHighPrice": 11.0, "targetLowPrice": 5.0, "targetMeanPrice": 8.0, "targetMedianPrice": 8.0, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 62330000, "totalCashPerShare": 0.314, "ebitda": -99299000, "totalDebt": 26906000, "quickRatio": 2.552, "currentRatio": 3.211, "totalRevenue": 308000, "debtToEquity": 23.085, "revenuePerShare": 0.002, "returnOnAssets": -0.27539, "returnOnEquity": -0.8316, "grossProfits": 308000, "freeCashflow": -54122000, "operatingCashflow": -82437000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": 5869.2, "financialCurrency": "USD", "symbol": "ATAI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1744932147, "regularMarketTime": 1744920002, "exchange": "NGM", "messageBoardId": "finmb_710359021", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 3.5211318, "regularMarketPrice": 1.47, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1624023000000, "postMarketChangePercent": 0.680271, "postMarketPrice": 1.48, "postMarketChange": 0.00999999, "regularMarketChange": 0.05000007, "regularMarketDayRange": "1.42 - 1.505", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 2782438, "fiftyTwoWeekLowChange": 0.44000006, "fiftyTwoWeekLowChangePercent": 0.42718452, "fiftyTwoWeekRange": "1.03 - 2.565", "fiftyTwoWeekHighChange": -1.095, "fiftyTwoWeekHighChangePercent": -0.4269006, "fiftyTwoWeekChangePercent": -21.390373, "earningsTimestamp": 1742212801, "earningsTimestampStart": 1747133940, "earningsTimestampEnd": 1747656000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.93, "epsForward": -0.68, "epsCurrentYear": -0.82667, "priceEpsCurrentYear": -1.7782187, "fiftyDayAverageChange": -0.14819992, "fiftyDayAverageChangePercent": -0.09158319, "twoHundredDayAverageChange": 0.03400004, "twoHundredDayAverageChangePercent": 0.023676908, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "shortName": "ATAI Life Sciences N.V.", "longName": "Atai Life Sciences N.V.", "ipoExpectedDate": "2021-06-18", "cryptoTradeable": false, "displayName": "Atai Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]